Abiopharma

🔍 McNamara Lauren (Executive)

Company: SunOpta Inc. (STKL)

Report Date: 2026-04-11

Detailed Transactions and Holdings:

• Acquired 6,201 shares of Common Shares (Direct)
  Date: 2026-04-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 134,897.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,828 shares of Common Shares at $6.48 per share (Direct)
  Date: 2026-04-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 132,069.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 6,201 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,401.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
• F2: This line item reflects the deemed disposition of shares withheld by the Company to satisfy income tax withholding requirements in connection with the vesting of the RSUs.
• F3: The Restricted Stock Units vest in three equal annual installments beginning on April 11, 2026, subject to the continued employment of the reporting person through each such vesting date.
• F4: The Restricted Stock Units do not have an expiration date.